P-026 pufs primary endpoint complications by aneurysm size

ConclusionsAll 6 major neurologic morbidity and neurologic mortality events in the PUFS trial was observed in 84 patients harboring large aneurysms, for 7% complication rate in this subgroup. Patients with giant aneurysms suffered no such complications, however, their parent vessel occlusion rates were higher at 18.2% (4/22). More aggressive or more prolonged antiplatelet treatment may be necessary in patients with giant aneurysms treated with flow diversion alone.DisclosuresT. Becske: 2; C; Proctor for Covidien. M. Potts: None. W. Brinjikji: None. D. Kallmes: 1; C; funding for enrollment in clinical trials. 2; C; Covidien: funding for Principal Investigator duties, Steering Committee and Adverse Event Adjudication Committee;. M. Shapiro: 2; C; Covidien proctor. P. Nelson: 2; C; Covidien proctor.

Source: Journal of NeuroInterventional Surgery - July 26, 2015 Category: Neurosurgery Authors: Becske, T., Potts, M., Brinjikji, W., Kallmes, D., Shapiro, M., Nelson, P. Tags: SNIS 12th Annual Meeting Oral Poster Abstracts Source Type: research